Negative association of acetate with visceral adipose tissue and insulin levels

Diabetes, Metabolic Syndrome and Obesity

Volumn 5, Issue , 2012, Pages 49-55

  Layden, Brian T ^a   Yalamanchi, Sudha K ^a   Wolever, Thomas M S ^b   Dunaif, Andrea ^a   Lowe, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Gut flora; Insulin; Obesity; Short chain fatty acids

Indexed keywords

ACETIC ACID; INSULIN; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; BIOLOGICAL TRAIT; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE MUCOSA; INTRAABDOMINAL FAT; OBESITY; ORAL GLUCOSE TOLERANCE TEST;

EID: 84859735360     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S29244     Document Type: Article

References (35)

1. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3(4):213-223.
2. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587(Pt 17):4153-4158.
3. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-1031.
4. Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Nat Acad Sci U S A. 2008;105(43):16767-16772.
5. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40(3):235-243.
6. Wolever TM, Josse RG, Leiter LA, Chiasson JL. Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism. 1997;46(7):805-811.
7. Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2010;18(1):190-195.
8. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 1997;100(5):1166-1173.
9. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002.
10. Sivan E, Boden G. Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep. 2003;3(4):319-322.
11. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006;55 Suppl 2:S16-S23.
12. Ximenes HM, Hirata AE, Rocha MS, Curi R, Carpinelli AR. Propionate inhibits glucose-induced insulin secretion in isolated rat pancreatic islets. Cell Biochem Func. 2007;25(2):173-178.
13. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33 Suppl 1:S11-S61.
14. Legro RS, Driscoll D, Strauss JF 3rd, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Nat Acad Sci U S A. 1998;95(25):14956-14960.
15. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol. 2001;281(2):E392-E399.
16. Vogt JA, Pencharz PB, Wolever TM. L-Rhamnose increases serum propionate in humans. Am J Clin Nutr. 2004;80(1):89-94.
17. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992;41(10):1257-1266.
18. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr. 1995;61(2):274-278.
19. Lopez S, Bermudez B, Abia R, Muriana FJ. The influence of major dietary fatty acids on insulin secretion and action. Curr Opin Lipidol. 2010;21(1):15-20.
20. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001;322(7288):716-720.
21. Demerath EW, Reed D, Rogers N, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr. 2008;88(5): 1263-1271.
22. Rytka JM, Wueest S, Schoenle EJ, Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes. 2011;60(1):56-63.
23. Skutches CL, Holroyde CP, Myers RN, Paul P, Reichard GA. Plasma acetate turnover and oxidation. J Clin Invest. 1979;64(3):708-713.
24. Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health. 2010;7(12):4281-4304.
25. Pouteau E, Piloquet H, Maugeais P, et al. Kinetic aspects of acetate metabolism in healthy humans using [1-13C] acetate. Am J Physiol. 1996;271(1 Pt 1):E58-E64.
26. Tollinger CD, Vreman HJ, Weiner MW. Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding, and various diseases. Clin Chem. 1979;25(10):1787-1790.
27. Zaibi MS, Stocker CJ, O'Dowd J, et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 2010;584(11):2381-2386.
28. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364-371.
29. Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13): 11312-11319.
30. Hong YH, Nishimura Y, Hishikawa D, et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005;146(12):5092-5099.
31. Karaki S, Mitsui R, Hayashi H, et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 2006;324(3):353-360.
32. Karaki S, Tazoe H, Hayashi H, et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008;39(2):135-142.
33. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003;303(4):1047-1052.
34. Regard JB, Kataoka H, Cano DA, et al. Probing cell type-specific functions of G(i) in vivo identifies GPCR regulators of insulin secretion. J Clin Invest. 2007;117(12):4034-4043.
35. Gutin B, Johnson MH, Humphries MC, et al. Relationship of visceral adiposity to cardiovascular disease risk factors in black and white teens. Obesity (Silver Spring). 2007;15(4):1029-1035.